Idenix Pharmaceuticals; Inc.;Idenix Pharmaceuticals, Inc.;Universita Degli Studi di Cagliari
发明人:
Jean-Pierre Sommadossi,Paulo LaColla
申请号：
US13623674
公开号：
US20130017171A1
申请日:
2012.09.20
申请国别(地区):
US
年份:
2013
代理人:
摘要：
A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.
